Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Albumin in decompensated cirrhosis: new concepts and perspectives
Mauro Bernardi, Paolo Angeli, J. J. Clariá, et al.
Gut (2020) Vol. 69, Iss. 6, pp. 1127-1138
Open Access | Times Cited: 270

Showing 1-25 of 270 citing articles:

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Scott W. Biggins, P. Angeli, Guadalupe García‐Tsao, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 1014-1048
Closed Access | Times Cited: 504
The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis
Vicente Arroyo, Paolo Angeli, Richard Moreau, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 670-685
Open Access | Times Cited: 312
Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction
Cornelius Engelmann, J. J. Clariá, Gyöngyi Szabó, et al.
Journal of Hepatology (2021) Vol. 75, pp. S49-S66
Open Access | Times Cited: 252
Hypoalbuminemia as Surrogate and Culprit of Infections
Christian J. Wiedermann
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4496-4496
Open Access | Times Cited: 186
Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment
Giacomo Zaccherini, Emmanuel Weiss, Richard Moreau
JHEP Reports (2020) Vol. 3, Iss. 1, pp. 100176-100176
Open Access | Times Cited: 145
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 145
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
Dalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 4, pp. 819-828
Open Access | Times Cited: 139
Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19
Gulam Rabbani, Saeyoung Nate Ahn
International Journal of Biological Macromolecules (2021) Vol. 193, pp. 948-955
Open Access | Times Cited: 113
Acute-on-chronic liver failure: Terminology, mechanisms and management
Vinay Kumar BR, Shiv Kumar Sarin
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 670-689
Open Access | Times Cited: 45
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
Marlene Christina Nielsen, Rasmus Hvidbjerg Gantzel, J. J. Clariá, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1175-1175
Open Access | Times Cited: 130
Where does TIPS fit in the management of patients with cirrhosis?
Juan Carlos García‐Pagán, Saad Saffo, Mattias Mandorfer, et al.
JHEP Reports (2020) Vol. 2, Iss. 4, pp. 100122-100122
Open Access | Times Cited: 105
Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure
Mireia Casulleras, Ingrid W. Zhang, Cristina López‐Vicario, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2632-2632
Open Access | Times Cited: 101
Plasma Albumin Levels Predict Risk for Nonsurvivors in Critically Ill Patients with Covid-19
Juyi Li, Meng Li, Shasha Zheng, et al.
Biomarkers in Medicine (2020) Vol. 14, Iss. 10, pp. 827-837
Open Access | Times Cited: 71
Albumin in Advanced Liver Diseases: The Good and Bad of a Drug!
Rakesh Kumar Jagdish, Jaswinder Singh Maras, Shiv Kumar Sarin
Hepatology (2021) Vol. 74, Iss. 5, pp. 2848-2862
Closed Access | Times Cited: 70
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
Maurizio Baldassarre, Marina Naldi, Giacomo Zaccherini, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 2058-2073
Open Access | Times Cited: 65
The multifactorial mechanisms of bacterial infection in decompensated cirrhosis
Van der Merwe, Shilpa Chokshi, Christine Bernsmeier, et al.
Journal of Hepatology (2021) Vol. 75, pp. S82-S100
Closed Access | Times Cited: 65
Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis
Qi Wang, Hong Zhao, You Deng, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1564-1572
Open Access | Times Cited: 56
Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts
Faouzi Saliba, Rafael Bañares, Fin Stolze Larsen, et al.
Intensive Care Medicine (2022)
Closed Access | Times Cited: 56
Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders
E. Sally Ward, Deborah Gelinas, Erwin Dreesen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure
Banwari Agarwal, Rafael Bañares, Faouzi Saliba, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 79-92
Open Access | Times Cited: 40
Long-term albumin treatment in patients with cirrhosis and ascites
Paolo Caraceni, Alastair O’Brien, Pere Ginès
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1306-1317
Open Access | Times Cited: 39
Albumin, an interesting and functionally diverse protein, varies from ‘native’ to ‘effective’ (Review)
Nijin Wu, Tiantian Liu, Miaomiao Tian, et al.
Molecular Medicine Reports (2023) Vol. 29, Iss. 2
Open Access | Times Cited: 27
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
Mattias Mandorfer, Elmar Aigner, Manfred Cejna, et al.
Wiener klinische Wochenschrift (2023) Vol. 135, Iss. S3, pp. 493-523
Open Access | Times Cited: 22
Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study
Fajuan Rui, Yee Hui Yeo, Liang Xu, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102419-102419
Open Access | Times Cited: 12
Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers
Jonel Trebicka, Rubén Hernáez, Debbie L. Shawcross, et al.
Gut (2024) Vol. 73, Iss. 6, pp. 1015-1024
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top